Exclusive Interview from AACE Orlando This is a 5-part transcript. Part 1 | Part 2 | Part 3 | Part 4 | Part 5 Steve Freed: Well, it’s a real honor to be here at AACE 2016 at Orlando. And to be with probably the most knowledgeable person when it …

A new weight loss device, AspireAssist, offers a novel approach to cutting calories: draining them from the stomach before they are fully digested. The AspireAssist® system consists of a thin tube implanted in the stomach, connecting to an outside port on the skin of the belly.

We certainly have important education to accomplish with patients and health professionals regarding the new higher concentration insulin products that are available only in a pen, including U-300 TOUJEO (insulin glargine), U-200 TRESIBA (insulin degludec), and U-200 HUMALOG (insulin lispro). U-500 insulin is also available in a pen (HUMULIN), although vials remain on the market. Patients may not understand proper dosing and dose measurement with these higher concentrations of insulin products.

Part 2 of our ADA Rundown checks out the latest information on competing long-acting insulins, and the ongoing research into potential class effect benefits for cardiovascular outcomes: as data shows CV benefits for DPP-4 and SGLT-2 treatments, are GLP-1 treatments under pressure?

In part 1 of our ADA Rundown, we look at cardiovascular benefits for multiple drugs, new combination treatments, and the possibility that Invokana's weight loss benefits may also apply to people who don't have diabetes.

With so much breaking news surrounding SGLT-2 Inhibitors at ADA, what conclusions can we draw? Viewpoints from our guest editorialist David Kliff, and DIC advisory board member Dr. George Bakris.

At the 2016 conference in New Orleans, the latest research on SGLT-2 Inhibitors was on display.

The National Institute of Health and Care Excellence (NICE) has recommended that SGLT-2 inhibitors on the UK market can be used earlier in patients with diabetes

Male, 32 years of age. Works erratic hours. Recently came up with a plan of how to remember to take his meds. He started setting up and taking his pill box with him. He has succeeded at taking his medications and taking them on time…all except his injectable medications.

Do you prefer to watch our video interviews with recognized diabetes doctors and experts, or read transcriptions of the interviews? 1) Videos 2) Transcripts 3) Both Please let us know -- follow the link to respond!